
Pulmonary arterial hypertension (PAH) is a major complication in systemic sclerosis (SSc), a disease marked by vascular and lymphatic vessel abnormalities. This study was undertaken to assess the role of the lymphangiogenic factors vascular endothelial growth factor C (VEGF‐C) and angiopoietin 2 (Ang‐2) and the soluble forms of their respective cognate receptors, soluble VEGF receptor 3 (sVEGFR‐3) and soluble TIE‐2, in patients with SSc, and to evaluate their predictive ability as markers for PAH development in SSc...
Like
Save
Share